Canagliflozin Targeting Vascular Inflammation
Canagliflozin Targeting Vascular Inflammation
Recruiting · NCT05427084 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Canagliflozin Targeting Vascular Inflammation | Arterial Occlusive Diseases, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, myocardial ischemia, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2026-05-06 | NCT05427084 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ottawa Heart Institute Research Corporation | 64 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Ottawa Heart Institute | Ottawa | Canada | 61 |